Select Medical Announces Take-Private Agreement and Q1 Financial Results
Select Medical announced a take-private agreement at $16.50 per share led by Robert Ortenzio, with an expected closing in mid-2026 contingent on financing and regulatory approvals. The company reported Q1 revenue growth of 5% year-over-year but faced margin pressure as adjusted EBITDA declined to $141.6 million.
Tickers: $SEM
Topics: inpatient rehab expansion Q1 earnings results take-private transaction